Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.50 |
| ▸ | PRKDC | P78527 | 12/20 | 0.43 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.39 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22173218 | 0.97 | ALOX5 (0.49) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL24936634 | 0.95 | ALOX5 (0.54) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL17038432 | 0.94 | ALOX5 (0.48) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL1687741 | 0.93 | ALOX5 (0.50) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL17038433 | 0.93 | ALOX5 (0.47) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL16904459 | 0.93 | ALOX5 (0.52) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL17038409 | 0.93 | ALOX5 (0.51) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL24811949 | 0.93 | ALOX5 (0.51) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL26788640 | 0.92 | ALOX5 (0.49) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL18020822 | 0.92 | ALOX5 (0.46) | ALOX5PRKDCGGPS1PTGES2PRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10707423-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-07-07 | — | — | US | disclosed |
| US-20160028021-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-01-28 | — | — | US | disclosed |
| EP-2966706-A2 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2016-01-13 | — | — | EP | disclosed |
| US-20150243894-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2015-08-27 | — | — | US | disclosed |
| US-20150243894-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160028021-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OR10J3 | ALOX5 336/4885PRKDC 4297/4885GGPS1 1495/4885 |
| US-10707423-B2 | Organic electroluminescent materials and devices | OCIAD1, OXA1L, SLCO2B1 | ALOX5 702/4885PRKDC 4699/4885GGPS1 1572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.